Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
25.22
+1.60 (6.77%)
Sep 21, 2026, 11:55 AM EDT - Market open
Amphastar Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Revenue | 730.02 | 720.53 | 719.89 | 723.76 | 720.74 | 725.71 | 712.81 | 681.49 | 644.52 | 610.85 | 593.24 | 572.61 | 540.89 | 518.64 | 498.99 | 484.85 | 476.92 | 455.12 | 437.77 | 412.8 |
Other Revenue | - | - | - | -0.46 | 1.94 | 4.95 | 19.15 | 42.06 | 68.37 | 65.36 | 51.16 | 28.7 | - | - | - | - | - | - | - | - |
| 730.02 | 720.53 | 719.89 | 723.31 | 722.68 | 730.66 | 731.97 | 723.55 | 712.89 | 676.21 | 644.4 | 601.31 | 540.89 | 518.64 | 498.99 | 484.85 | 476.92 | 455.12 | 437.77 | 412.8 | |
Revenue Growth (YoY) | 1.02% | -1.39% | -1.65% | -0.03% | 1.37% | 8.05% | 13.59% | 20.33% | 31.80% | 30.38% | 29.14% | 24.02% | 13.41% | 13.96% | 13.98% | 17.45% | 24.19% | 23.61% | 25.13% | 22.38% |
Cost of Revenue | 381.91 | 379.4 | 363.83 | 366.27 | 362.35 | 361.65 | 358.11 | 340.2 | 320.38 | 308.83 | 293.27 | 272.46 | 264.63 | 249.07 | 250.13 | 250.93 | 250.32 | 244.5 | 238.03 | 232.47 |
Gross Profit | 348.11 | 341.13 | 356.06 | 357.04 | 360.33 | 369.01 | 373.86 | 383.35 | 392.51 | 367.38 | 351.12 | 328.85 | 276.26 | 269.57 | 248.86 | 233.93 | 226.6 | 210.62 | 199.74 | 180.34 |
Selling, General & Admin | 116.15 | 108.8 | 106.71 | 103.32 | 99.27 | 97.34 | 94.52 | 92.9 | 88.15 | 84.85 | 80.39 | 74.75 | 72.46 | 69.2 | 66.59 | 63.39 | 62.28 | 65.23 | 67.12 | 67.74 |
Research & Development | 94.57 | 92.49 | 85.84 | 80.67 | 79.4 | 76.97 | 73.91 | 76.19 | 71.78 | 70.97 | 73.74 | 70.56 | 72.41 | 78.36 | 74.77 | 74.82 | 67.07 | 62.39 | 60.93 | 61.78 |
Operating Expenses | 210.72 | 201.29 | 192.55 | 183.99 | 178.66 | 174.3 | 168.44 | 169.09 | 159.92 | 155.82 | 154.13 | 145.31 | 144.87 | 147.56 | 141.36 | 138.21 | 129.34 | 127.62 | 128.05 | 129.52 |
Operating Income | 137.39 | 139.84 | 163.5 | 173.04 | 181.67 | 194.7 | 205.42 | 214.26 | 232.59 | 211.56 | 196.99 | 183.54 | 131.39 | 122.02 | 107.5 | 95.72 | 97.26 | 83 | 71.69 | 50.81 |
Interest Expense | -21.73 | -25.15 | -29.78 | -33.28 | -41.09 | -41.12 | -35.34 | -43.57 | -38.28 | -36.07 | -33.06 | -21.43 | -11.19 | -1.89 | -1.85 | - | - | -1.14 | -0.89 | -0.81 |
Interest & Investment Income | 9.36 | 8.99 | 8.68 | 8.55 | 8.73 | 10.15 | 10.61 | 10.62 | 9.4 | 7.09 | 5.46 | 3.74 | 2.87 | 2.06 | 1.32 | 5.31 | 3.16 | 0.62 | 0.6 | 0.57 |
Earnings From Equity Investments | - | - | - | - | - | - | -0.57 | -1.08 | -1.47 | -1.77 | -1.98 | -1.53 | -1.31 | -1.26 | -1.18 | -1.33 | -1.17 | -0.91 | -0.21 | - |
Currency Exchange Gain (Loss) | -4.9 | - | - | - | 3.9 | - | - | - | - | - | - | 5.61 | - | - | - | -5.61 | - | - | - | - |
Other Non Operating Income (Expenses) | 5.01 | 2.23 | 4.32 | 10.46 | 8.63 | 9.02 | 9.08 | 5.84 | 2.1 | 3.08 | 1.97 | 2.52 | -3.63 | 1.09 | 9.07 | 1.92 | 9.19 | 2.99 | 13.54 | 1.17 |
EBT Excluding Unusual Items | 125.12 | 125.91 | 146.72 | 158.77 | 161.84 | 172.75 | 189.19 | 186.07 | 204.33 | 183.9 | 169.38 | 172.44 | 118.13 | 122.02 | 114.86 | 96.01 | 108.44 | 84.56 | 84.73 | 51.75 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.59 | 13.59 | - | 13.59 |
Asset Writedown | - | - | - | - | - | - | - | - | -2.7 | - | - | -2.7 | - | -2.7 | - | - | - | - | - | - |
Legal Settlements | -23.1 | -23.1 | -23.1 | -23.1 | - | - | - | - | - | - | - | - | 10.8 | - | - | 6.4 | -4.4 | 10.8 | 1 | -12.8 |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.8 | -1.8 | -1.8 | -1.8 | -2.3 |
Pretax Income | 102.02 | 102.81 | 123.62 | 135.67 | 161.84 | 172.75 | 189.19 | 186.07 | 201.63 | 183.9 | 169.38 | 169.74 | 128.93 | 119.32 | 114.86 | 100.61 | 115.83 | 107.15 | 83.93 | 50.24 |
Income Tax Expense | 23.48 | 23.59 | 25.53 | 24.04 | 27.13 | 31.12 | 29.67 | 28.35 | 35.12 | 29.21 | 31.83 | 34.45 | 26.98 | 26.15 | 23.48 | 23.38 | 23.51 | 23.55 | 20.63 | 12.49 |
Earnings From Continuing Operations | 78.55 | 79.23 | 98.09 | 111.63 | 134.71 | 141.63 | 159.52 | 157.72 | 166.52 | 154.69 | 137.55 | 135.29 | 101.94 | 93.17 | 91.39 | 77.23 | 92.32 | 83.6 | 63.3 | 37.75 |
Minority Interest in Earnings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.41 | -2.27 | -1.19 | -1.67 |
Net Income | 78.55 | 79.23 | 98.09 | 111.63 | 134.71 | 141.63 | 159.52 | 157.72 | 166.52 | 154.69 | 137.55 | 135.29 | 101.94 | 93.17 | 91.39 | 77.23 | 90.91 | 81.33 | 62.12 | 36.08 |
Net Income to Common | 78.55 | 79.23 | 98.09 | 111.63 | 134.71 | 141.63 | 159.52 | 157.72 | 166.52 | 154.69 | 137.55 | 135.29 | 101.94 | 93.17 | 91.39 | 77.23 | 90.91 | 81.33 | 62.12 | 36.08 |
Net Income Growth (YoY) | -41.69% | -44.06% | -38.51% | -29.22% | -19.10% | -8.45% | 15.98% | 16.58% | 63.34% | 66.04% | 50.51% | 75.17% | 12.14% | 14.56% | 47.12% | 114.04% | 769.59% | 3159.64% | 4327.37% | 442.60% |
Shares Outstanding (Basic) | 45 | 46 | 47 | 47 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 49 | 49 | 48 | 48 | 48 | 48 | 48 |
Shares Outstanding (Diluted) | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 52 | 53 | 53 | 53 | 53 | 52 | 52 | 52 | 52 | 51 | 50 | 50 | 50 |
Shares Change (YoY) | -7.79% | -7.65% | -7.38% | -6.16% | -5.10% | -3.73% | -1.78% | -0.36% | 1.15% | 1.60% | 1.09% | 1.27% | 2.10% | 4.02% | 5.31% | 4.65% | 3.33% | 1.94% | 1.34% | 1.43% |
EPS (Basic) | 1.73 | 1.72 | 2.10 | 2.36 | 2.82 | 2.93 | 3.29 | 3.26 | 3.44 | 3.20 | 2.85 | 2.80 | 2.11 | 1.92 | 1.88 | 1.59 | 1.89 | 1.70 | 1.30 | 0.76 |
EPS (Diluted) | 1.69 | 1.67 | 2.03 | 2.27 | 2.68 | 2.77 | 3.06 | 3.01 | 3.15 | 2.91 | 2.60 | 2.56 | 1.94 | 1.77 | 1.74 | 1.49 | 1.77 | 1.62 | 1.25 | 0.72 |
EPS Growth (YoY) | -37.04% | -39.73% | -33.66% | -24.59% | -14.81% | -4.83% | 17.69% | 17.38% | 62.07% | 64.18% | 49.43% | 72.29% | 9.55% | 9.16% | 39.20% | 106.09% | 739.76% | 3024.16% | 4090.97% | 435.38% |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | 152.89 | 135.19 | 121.23 | 113.26 | 112.19 | 150.23 | 172.35 | 170.15 | 178.13 | 160.93 | 145.34 | 139.83 | 100.44 | 51.43 | 65.15 | 89.79 | 70.39 | 99.96 | 70.54 | 44.54 |
Free Cash Flow Per Share | 3.30 | 2.85 | 2.51 | 2.30 | 2.23 | 2.93 | 3.31 | 3.24 | 3.36 | 3.02 | 2.74 | 2.65 | 1.92 | 0.98 | 1.24 | 1.73 | 1.37 | 1.98 | 1.42 | 0.90 |
Gross Margin | 47.69% | 47.34% | 49.46% | 49.36% | 49.86% | 50.50% | 51.08% | 52.98% | 55.06% | 54.33% | 54.49% | 54.69% | 51.08% | 51.98% | 49.87% | 48.25% | 47.51% | 46.28% | 45.63% | 43.69% |
Operating Margin | 18.82% | 19.41% | 22.71% | 23.92% | 25.14% | 26.65% | 28.06% | 29.61% | 32.63% | 31.29% | 30.57% | 30.52% | 24.29% | 23.53% | 21.54% | 19.74% | 20.39% | 18.24% | 16.38% | 12.31% |
Profit Margin | 10.76% | 11.00% | 13.63% | 15.43% | 18.64% | 19.38% | 21.79% | 21.80% | 23.36% | 22.88% | 21.34% | 22.50% | 18.85% | 17.96% | 18.31% | 15.93% | 19.06% | 17.87% | 14.19% | 8.74% |
Free Cash Flow Margin | 20.94% | 18.76% | 16.84% | 15.66% | 15.52% | 20.56% | 23.54% | 23.52% | 24.99% | 23.80% | 22.55% | 23.25% | 18.57% | 9.92% | 13.06% | 18.52% | 14.76% | 21.96% | 16.11% | 10.79% |
EBITDA | 194.51 | 197.27 | 220.2 | 228.83 | 236.73 | 248.3 | 258.39 | 266.61 | 284.16 | 256.09 | 235.02 | 215.17 | 156.84 | 147.31 | 132.27 | 119.82 | 120.66 | 106.49 | 94.95 | 74.35 |
EBITDA Margin | 26.65% | 27.38% | 30.59% | 31.64% | 32.76% | 33.98% | 35.30% | 36.85% | 39.86% | 37.87% | 36.47% | 35.78% | 29.00% | 28.40% | 26.51% | 24.71% | 25.30% | 23.40% | 21.69% | 18.01% |
D&A For EBITDA | 57.13 | 57.43 | 56.7 | 55.79 | 55.06 | 53.59 | 52.97 | 52.36 | 51.57 | 44.53 | 38.04 | 31.63 | 25.45 | 25.3 | 24.77 | 24.1 | 23.4 | 23.49 | 23.27 | 23.54 |
EBIT | 137.39 | 139.84 | 163.5 | 173.04 | 181.67 | 194.7 | 205.42 | 214.26 | 232.59 | 211.56 | 196.99 | 183.54 | 131.39 | 122.02 | 107.5 | 95.72 | 97.26 | 83 | 71.69 | 50.81 |
EBIT Margin | 18.82% | 19.41% | 22.71% | 23.92% | 25.14% | 26.65% | 28.06% | 29.61% | 32.63% | 31.29% | 30.57% | 30.52% | 24.29% | 23.53% | 21.54% | 19.74% | 20.39% | 18.24% | 16.38% | 12.31% |
Effective Tax Rate | 23.01% | 22.94% | 20.65% | 17.72% | 16.77% | 18.02% | 15.68% | 15.24% | 17.42% | 15.88% | 18.79% | 20.30% | 20.93% | 21.92% | 20.44% | 23.24% | 20.30% | 21.98% | 24.58% | 24.86% |
Revenue as Reported | 719.89 | 719.89 | 719.89 | 723.31 | 377.74 | 560.13 | 731.97 | 723.55 | 712.89 | 676.21 | 644.4 | 601.31 | 784.72 | 639.01 | 498.99 | 363.96 | - | - | 437.77 | - |
Advertising Expenses | - | - | 10.2 | - | - | - | 10.5 | - | - | - | 10.4 | - | - | - | 8.7 | - | - | - | 8.1 | - |